New RSV vaccine for seniors not covered in New Brunswick
CBC
New Brunswick's RSV season is underway with 11 confirmed cases so far, but any seniors interested in getting the new vaccine against respiratory syncytial virus will have to pay for it themselves.
Meanwhile, no decision has been made yet on the use of a new antibody injection to protect babies from serious illness caused by the virus.
And there's still no word on whether the province will make RSV a reportable disease, like COVID-19 and the flu.
Last fall and winter, New Brunswick recorded more than 1,500 RSV cases — the highest number in at least a decade.
The Department of Health is aware Health Canada approved Arexvy — the first RSV vaccine for people aged 60 and older
More Related News